Literature DB >> 29713885

Supracricoid partial laryngectomy for radiorecurrent laryngeal cancer: a systematic review of the literature and meta-analysis.

Armando De Virgilio1, Raul Pellini2, Giuseppe Mercante2, Giovanni Cristalli2, Valentina Manciocco2, Diana Giannarelli3, Giuseppe Spriano2.   

Abstract

PURPOSE: The objective of the current systematic review with meta-analysis was to report the pooled survival outcomes of supracricoid partial laryngectomy in the setting of radiorecurrent laryngeal cancer to investigate if and when an organ-sparing surgical treatment is adequate.
METHODS: The search included all original papers from 1990 to December 2017. The search terms included the following: cricohyoepiglottopexy; cricohyoidopexy; cricohyopexy; horizontal laryngectomy; and partial, subtotal, supracricoid, and supraglottic laryngectomy. Inclusion criteria were as follows: (1) data clearly distinguish results of partial laryngeal procedures; (2) clear description of tumor stage and selection criteria; (3) clear description or derivability of local control and survival rates.
RESULTS: Eleven out of 270 papers were analyzed, and a total of 251 cases were included. Two-year LC, 3-year DFS, and 5-year OS were 92, 80, and 79%, respectively. Heterogenicity evaluated with the I2 parameter was 14, 0, 0%, respectively. The larynx preservation rate was 85.2%, the decannulation rate was 92.1%, and swallowing recovery was 96.5% (PEG dependence and the aspiration pneumonia rate were 3.5 and 6.4%, respectively).
CONCLUSIONS: SCPL is oncologically sound, guaranteeing a high percentage of success. The homogeneity of data should encourage the use of SCPL as salvage treatment for recurrent LSCC.

Entities:  

Keywords:  Laryngeal squamous cell carcinoma; Open partial laryngectomy; Radiorecurrent laryngeal cancer; Supracricoid laryngectomy; Systematic review

Mesh:

Year:  2018        PMID: 29713885     DOI: 10.1007/s00405-018-4986-4

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  36 in total

Review 1.  Do the findings of case series studies vary significantly according to methodological characteristics?

Authors:  K Dalziel; A Round; K Stein; R Garside; E Castelnuovo; L Payne
Journal:  Health Technol Assess       Date:  2005-01       Impact factor: 4.014

2.  Supracricoid partial laryngectomies after failure of radiation therapy.

Authors:  Marc Makeieff; Delphine Venegoni; Guisepe Mercante; Louis Crampette; Bernard Guerrier
Journal:  Laryngoscope       Date:  2005-02       Impact factor: 3.325

3.  Supracricoid partial laryngectomy as salvage surgery for radiation therapy failure.

Authors:  Alberto Deganello; Oreste Gallo; Jano Maria De Cesare; Maria Benedetta Ninu; Gianni Gitti; Luca de' Campora; Marco Radici; Enrico de' Campora
Journal:  Head Neck       Date:  2008-08       Impact factor: 3.147

4.  Clinical outcome of supracricoid laryngectomy with cricohyoidoepiglottopexy: radiation failure versus previously untreated patients.

Authors:  Meijin Nakayama; Makito Okamoto; Kazushige Hayakawa; Hiromichi Ishiyama; Shouko Kotani; Shunsuke Miyamoto; Yutomo Seino; Tabito Okamoto; Itaru Soda; Akane Sekiguchi
Journal:  Auris Nasus Larynx       Date:  2012-08-11       Impact factor: 1.863

5.  Carcinoma of the oral cavity. factors affecting treatment failure at the primary site and neck.

Authors:  J P Shah; R A Cendon; H W Farr; E W Strong
Journal:  Am J Surg       Date:  1976-10       Impact factor: 2.565

6.  [Prosthetic voice rehabilitation after laryngectomy. Failures and complications after previous radiation therapy].

Authors:  P Kummer; M Chahoud; M Schuster; U Eysholdt; F Rosanowski
Journal:  HNO       Date:  2006-04       Impact factor: 1.284

7.  Oncologic results of the surgical salvage of recurrent laryngeal squamous cell carcinoma in a multicentric retrospective series: emerging role of supracricoid partial laryngectomy.

Authors:  Marco de Vincentiis; Armando De Virgilio; Francesco Bussu; Roberto Gallus; Andrea Gallo; Giovanni Bastanza; Claudio Parrilla; Antonio Greco; Jacopo Galli; Rosaria Turchetta; Giovanni Almadori; Giulio Pagliuca; Vincenzo Valentini; Gaetano Paludetti
Journal:  Head Neck       Date:  2014-04-17       Impact factor: 3.147

8.  Supracricoid partial laryngectomy with cricohyoidoepiglottopexy in patients with radiation therapy failure.

Authors:  Kuauhyama Luna-Ortiz; Philippe Pasche; Mario Tamez-Velarde; Veronica Villavicencio-Valencia
Journal:  World J Surg Oncol       Date:  2009-12-19       Impact factor: 2.754

9.  Carbon dioxide laser salvage surgery after radiotherapy failure in T1 and T2 glottic carcinoma.

Authors:  Roberto Puxeddu; Cesare Piazza; Maria C Mensi; Gian Peppino Ledda; Federico Argiolas; Giorgio Peretti
Journal:  Otolaryngol Head Neck Surg       Date:  2004-01       Impact factor: 3.497

10.  Surgery after organ preservation therapy. Analysis of wound complications.

Authors:  A M Sassler; R M Esclamado; G T Wolf
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1995-02
View more
  3 in total

Review 1.  Current Role of Total Laryngectomy in the Era of Organ Preservation.

Authors:  Alexandre Bozec; Dorian Culié; Gilles Poissonnet; Olivier Dassonville
Journal:  Cancers (Basel)       Date:  2020-03-03       Impact factor: 6.639

2.  Transoral Robotic Surgery for Early-T Stage Glottic Cancer Involving the Anterior Commissure-News and Update.

Authors:  Chen-Chi Wang; Wen-Jiun Lin; Jing-Jie Wang; Chien-Chih Chen; Kai-Li Liang; Yen-Jung Huang
Journal:  Front Oncol       Date:  2022-01-31       Impact factor: 6.244

3.  Salvage carbon dioxide transoral laser microsurgery for laryngeal cancer after (chemo)radiotherapy: a European Laryngological Society consensus statement.

Authors:  Cesare Piazza; Alberto Paderno; Elisabeth V Sjogren; Patrick J Bradley; Hans E Eckel; Antti Mäkitie; Nayla Matar; Vinidh Paleri; Giorgio Peretti; Roberto Puxeddu; Miquel Quer; Marc Remacle; Vincent Vander Poorten; Isabel Vilaseca; Ricard Simo
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-07-05       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.